Schaffer's
Filament Health Enters Into Exclusive License Agreement With University Of Alabama at Birmingham For Data From A Clinical Trial Of Psilocybin For The Treatment Of Cocaine Use Disorder
Filament Health Announces Authorization Of Phase 2 Clinical Trial Studying Botanical Psilocybin For Prolonged Grief Disorder
Filament Health Announces Transition From OTCQB To OTC Pink Limited
.jpg)